Please login to the form below

Not currently logged in
Email:
Password:

Emperra appoints Bent Johnsen as CEO

He also takes on an MD role at the German digital health start-up

Bent JohnsenDigital health and medical device start-up Emperra has appointed Bent Johnsen as its CEO and managing director at time when the group bolsters Esysta, a diabetes management system that is expected to be available internationally.

Johnsen’s expertise lies in the health care sector and he has held several executive leadership positions within the field of diabetes working for insulin manufacturing companies as well as other global medical device firms.

As part of that he had a 15-year spell with Novo Nordisk, where his roles included general manager for its affiliates in Finland and the Baltic region, general manager for Poland and VP of US marketing.

He said: “I am very excited about the Esysta solution and its benefits for patients, doctors and nurses.

“The data is supported using algorithms and is the most comprehensive system available on the market.

“I’m looking forward to expanding this concept within our organisation or via strategic partners.”

Johnsen succeeds Dr Christian Krey who will be leaving the company by the end of June 2017.

Dr Klaus Stöckemann, chairman of the board at Emperra, said: “It is a great pleasure to welcome Mr. Johnsen as the new CEO of Emperra.”

“His solid international management experience is seen as very valuable at this stage where Emperra is progressing rapidly to make the innovative Esysta available both in Germany and internationally.”

6th June 2017

From: Research

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

What challenges still face clinical trial recruitment and retention?
Discover the reasons for the current clinical trial recruitment challenges facing pharma and the life sciences industry, and how the search for solutions to the problem continues...
“Fake News” and Credibility in Medical Publishing
Natalie Yeadon from Impetus Digital shares her thoughts on fighting fake news in Pharma and healthcare....
Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...

Infographics